Raffles Medical net profit falls 9.6% to $29m in H1

Its healthcare services division posted a 16% drop in revenue to $119.5m.

Raffles Medical Group’s net profit declined 9.6% to $29m in the first half of 2026, from $32.1m a year earlier.

Revenue decreased 6.7% to $353.2m, whilst operating profit fell 8.4% to $38.1m.

EBITDA also went down by 5.6% to $60.1m.

The decline came as the healthcare services division posted a 16% drop in revenue to $119.5m, due to lower occupancy at transitional care facilities. Profit from the segment fell to $15.6m from $24.9m.

This was partly offset by stronger performance from hospital services, where profit rose 11% to $19.7m. Revenue from the division stood at $170.2m, whilst its profit margin improved to 11.6% from 10.2%.

The group generated $64.6m in operating cash flow, up from $56.6m a year earlier.

It held $262.3m in cash and cash equivalents as at end-June, after distributing $55.2m in dividends and repaying $51.1m in bank loans.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia